Systemic mycoses in children. II.
D000196:Actinomycosis / Q000175:diagnosis / Q000188:drug therapy; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000628:therapy; D002177:Candidiasis / Q000188:drug therapy; D002648:Child; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D005658:Fungi; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009181:Mycoses; D010866:Natamycin / Q000627:therapeutic use; D009617:Nocardia Infections / Q000175:diagnosis / Q000628:therapy; D009616:Nocardia asteroides; D011193:Potassium Iodide / Q000627:therapeutic use; D013174:Sporotrichosis / Q000175:diagnosis / Q000188:drug therapy; D013266:Stilbamidines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D000935:Antifungal Agents; D013266:Stilbamidines; D013449:Sulfonamides; D011193:Potassium Iodide; D000666:Amphotericin B; D010866:Natamycin; D005437:Flucytosine